Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma

BACKGROUND: Anaplastic thyroid carcinoma (ATC) is a rare but deadly form of thyroid cancer. Kinase inhibitors kinase inhibitors have shown clinical efficacy in the management of ATC, however, eventually these tumors acquire resistance to KI and patients succumb to their disease. Salvage therapy in t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Iyer, Priyanka C., Dadu, Ramona, Gule-Monroe, Maria, Busaidy, Naifa L., Ferrarotto, Renata, Habra, Mouhammed Amir, Zafereo, Mark, Williams, Michelle D., Gunn, G. Brandon, Grosu, Horiana, Skinner, Heath D., Sturgis, Erich M., Gross, Neil, Cabanillas, Maria E.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6042271/
https://ncbi.nlm.nih.gov/pubmed/29996921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0378-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados